LARYNGEAL FUNCTION OUTCOMES IN CHILDREN POST-AIRWAY RECONSTRUCTION FOLLOWING INJECTION LARYNGOPLASTY By Ruhi Ahluwalia A THESIS Submitted to Michigan State University in partial fulfillment of the requirements for the degree of Communicative Sciences and Disorders – Master of Arts 2017 ABSTRACT LARYNGEAL FUNCTION OUTCOMES IN CHILDREN POST-AIRWAY RECONSTRUCTION FOLLOWING INJECTION LARYNGOPLASTY By Ruhi Ahluwalia Laryngotracheal stenosis is defined as congenital or acquired narrowing of the airway that may affect the glottis, subglottis, and/or trachea. Subglottic stenosis (SGS) is narrowing of the upper airway extending from just below the vocal folds to the lower border of the cricoid cartilage. Perceptually, a child with SGS may present with stridor and/or respiratory distress, due to decreased vocal fold medialization, resulting in need for airway reconstruction to provide an adequate airway and restore proper respiratory function. A common outcome of airway reconstruction procedures is unilateral vocal fold paralysis or paresis resulting in glottal insufficiency. Glottal insufficiency is one of the most common contributing factors in patients who present with dysphonia. Approximately half of children who undergo airway reconstruction are known to have dysphonia, or hoarse voice, which is said to have a negative influence on wellbeing. Voice therapy may provide improvement in vocal function in some cases; however, surgical intervention is required to improve vocal fold medialization by means of injection laryngoplasty. Currently, there is a lack of research for vocal fold medialization in the pediatric population as well as no research, to date, that assesses which injections are most effective in restoring vocal function. This study was a retrospective case series and medical record review which sought to determine efficacy of injection laryngoplasty and the parameters by which it is impacted. It was found that gender was the closest in correlation with glottal efficiency. Further research is warranted to determine a formal algorithm to assess vocal outcomes post-injection laryngoplasty. ACKNOWLEDGMENTS I would like to express my sincere gratitude to my advisor, Dr. Dimitar Deliyski, for the continuous support, patience, motivation, and immense knowledge shared throughout my thesis research. Thank you for always being willing to help and share your incredible stories when the stress of graduate school was at its max. I would also like to thank Stephanie Zacharias, Ph.D., CCC-SLP, Maryam Naghibolhosseini, Ph.D., Dr. Peter Lapine, Ph.D., and Dr. Alessandro de Alarcon for their ongoing support, advice, and encouragement. An additional thank you to Meredith Tabangin for conducting statistical analyses for this project and to the Division of Pediatric Otolaryngology and the Center for Pediatric Voice Disorders at Cincinnati Children’s Hospital Medical Center for providing data for this study. Finally, I would like to express my profound gratitude to my parents, sister, and fiancé for providing me with unfailing support and continuous encouragement throughout my academic career and through the process of researching and writing this thesis. This accomplishment would not have been possible without them. Blessed is truly an understatement. I love you. iii TABLE OF CONTENTS LIST OF TABLES .........................................................................................................................v LIST OF FIGURES ..................................................................................................................... vi KEY TO ABBREVIATIONS .................................................................................................... vii 1. INTRODUCTION .....................................................................................................................1 1.2 Airway Reconstruction .........................................................................................................1 1.2 Pediatric Voice Disorders .....................................................................................................2 1.3 Perceptual Outcomes .............................................................................................................3 1.4 Injection Laryngoplasty .........................................................................................................4 1.5 Glottal efficiency ...................................................................................................................6 1.6 Current study..........................................................................................................................7 2. RESEARCH DESIGN AND METHODS ................................................................................8 2.1 Participants ............................................................................................................................8 2.2 Data Collection .....................................................................................................................8 2.2.1 Pediatric Voice Handicap Index .................................................................................8 2.2.2 Acoustic Data ..............................................................................................................8 2.2.3 Aerodynamic Data .....................................................................................................9 2.2.4 Stroboscopy...............................................................................................................10 2.2.5 Glottal Efficiency ......................................................................................................10 2.3 Data Analysis ......................................................................................................................11 3. RESULTS .................................................................................................................................12 3.1 Perceptual Outcomes ..........................................................................................................12 3.2 Glottal Efficiency .................................................................................................................12 4. DISCUSSION ...........................................................................................................................17 5. CONCLUSION ........................................................................................................................19 APPENDICES ..............................................................................................................................21 APPENDIX A. Initial Intake History Form...............................................................................22 APPENDIX B. Pediatric Voice Handicap Index (pVHI) ..........................................................27 APPENDIX C. Stroboscopy Evaluation Form ..........................................................................30 APPENDIX D. Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) ....................34 BIBLIOGRAPHY ........................................................................................................................35 iv LIST OF TABLES Table 1. pVHI outcomes ................................................................................................................12 Table 2. Participant demographics, age at airway reconstruction and injection and GE percent change ............................................................................................................................................13 Table 3. Wilcoxon sum rank test median and interquartile range (IQR, 25th-75th percentile) of three parameters by GE ..................................................................................................................14 Table 4. Difference in glottal efficiency by sex, injection material and site of injection (p values) ........................................................................................................................................................15 v LIST OF FIGURES Figure 1. Injection Laryngoplasty ....................................................................................................6 Figure 2. Acoustic data collection ...................................................................................................9 Figure 3. Aerodynamic data collection ..........................................................................................10 Figure 4. GE pre- and post-injection laryngoplasty .......................................................................13 Figure 5. GE by sex .......................................................................................................................15 Figure 6. GE by injection material .................................................................................................15 Figure 7. GE by site of injection ....................................................................................................16 vi KEY TO ABBREVIATIONS SGS Subglottic Stenosis pVHI Pediatric Voice Handicap Index GE Glottal Efficiency CAPE-V Consensus Auditory-Perceptual Evaluation of Voice PAS Phonatory Aerodynamic System CSL Computerized Speech Lab v vii 1. INTRODUCTION The congenital or acquired narrowing of the airway, laryngotracheal stenosis, is commonly found at the level of the glottis, subglottic, and/or trachea (Lesperance & Zalzal, 1998). SGS is characterized by a narrowing of the upper airway extending from just below the vocal folds to the lower border of the cricoid cartilage. Acquired SGS typically results from prolonged endotracheal intubation or direct laryngotracheal injury (e.g. trauma, burn, and/or traumatic intubation); in cases such as these, prolonged intubation refers to a time period greater than 14 days. In the pediatric population, such airway injuries are noted with premature or critically ill babies whose pulmonary condition necessitates ongoing airway management. Congenital subglottic stenosis, on the other hand, occurs as a rare birth defect or results from a genetic syndrome where the airway remains narrow. Often, a child with SGS may present with stridor and/or respiratory distress for which airway reconstruction is warranted. 1.1 Airway Reconstruction The level of airway obstruction in individuals with SGS is rated using the Myer-Cotton staging system: Grade I lesions have less than 50% obstruction, Grade II lesions have 51% to 70% obstruction, Grade III lesions have 71% to 99% obstruction, and Grade IV lesions have no detectable lumen or complete stenosis (Myer, O’Connor, & Cotton, 1994). Once the level of obstruction has been determined, a surgical technique is selected to establish an adequate airway; this is done so by ways of airway reconstruction including laryngotracheoplasty, laryngotracheal reconstruction, cricotracheal resection, or laryngofissure. A child with Grade I or II SGS is typically treated with endoscopic surgery or tracheal balloon dilation; however, concomitant airway lesions have been significantly associated with failure of balloon dilation treatment (Whigham et al., 2012), potentially resulting in another surgery or other airway issues. Children 1 with Grade III and IV SGS are treated with laryngotracheal reconstruction, single- or doublestaged. Laryngotracheal reconstruction is used to increase the airway lumen by splitting the narrowed segment of the cartilaginous rings and then suturing harvested cartilage grafts to increase the lumen’s diameter of the trachea. Crichotracheal resection is where the narrowed part of the airway, just below the larynx, is removed and the larynx and trachea are sewn back together. Cricotracheal resection can also be single- or double-staged depending on where the narrowing occurs. A laryngofissure is performed by vertically splitting the thyroid cartilage exactly in the midline and widely opening up the immediate subglottic larynx. Wright (2008) found, however, that laryngofissures do tend to increase the chances of significant vocal fold edema. 1.2 Pediatric Voice Disorders Airway reconstruction is the recommended method to restore respiratory function by providing an adequate airway; however, this often results in poor glottal closure and allows for air to escape through the glottis during phonation (Ojha, Setlur, Bunting & Hartnick, 2015). This incomplete glottal closure results in dysphonia. Dysphonia is defined as a disorder characterized by altered vocal quality that impairs communication or reduces voice-related quality of life (Schwartz et al., 2009) and review of literature has shown that 69% of children present with dysphonia following laryngotracheal reconstruction (Sell & McCurtain, 1988). Additionally, a study by Baker et al. (2006) found that approximately half of children who undergo airway reconstruction are known to have dysphonia as a result of altered laryngeal anatomy. Vocal folds are the most common phonation source for individuals; during phonation the folds are brought together (adducted), airflow from the lungs is temporarily blocked, subglottal pressure then increases and the vocal folds are pushed back open (abducted). This continuous adductionabduction pattern results in phonation (voice). Disruption of this adduction-abduction pattern 2 results in dysphonic speech. In order to prevent air from escaping and regulate the vocal fold pattern, compensatory strategies (i.e. use of the ventricular folds, arytenoids against the petiole of the epiglottis, or arytenoids against the ventricular folds) are used therefore resulting in supraglottic phonation. Voice therapy can minimize supraglottic compression and reduce compensatory strategies (Ojha, Setlur, Bunting & Hartnick, 2015) by teaching individuals to increase breath support, decrease excess muscle tension, improve vocal fold closure, and decrease vocal effort and fatigue. The most common techniques used in voice therapy for individuals with dysphonia are diaphragmatic breathing, lip trills, stretching, and neck and laryngeal massage (Verdolini, 1998). What happens, however, when a patient is not completely satisfied or when maximum vocal function is not achieved? Ojha, Setlur, Bunting and Hartnick (2015) report that although some information is available, more efforts need to be made to address the issue of dysphonia in children with laryngotracheal reconstruction; more specifically, further research is required to determine how injectables may or may not correct any residual dysphonia. 1.3 Perceptual Outcomes Children with dysphonia often experience social withdrawal and depression, which may result in a negative influence on functional, emotional, educational and social outcomes (Baker et al., 2006). Literature in voice has an abundance of studies related to and studying the effects of voice disorders in adults, but limited research has been done with the pediatric population. A study by Zur et al. (2007) both developed and found the Pediatric Voice Handicap Index (pVHI), a modified version of the Voice Handicap Index, to be highly reliable in evaluating the effects of dysphonia on functional, physical and emotional well-being. The 30-item survey reflects the parents’ responses about his or her child with statements such as: “my child’s voice makes it difficult for people to hear him/hear”, “my child runs out of air when talking”, “people seem 3 irritated with my child’s voice” (Appendix B). It is strongly recommended that patients receive an early postoperative evaluation, following airway reconstruction, by a speech-language pathologist in order to prevent or treat potential development of poor-quality, supraglottic voice, and other poor vocal habits that may occur following airway reconstruction surgery (White et al., 2009). Speech-language pathologists work with these individuals on relaxation and voice exercises to help eliminate these compensatory strategies and restore the voice to its normal function. 1.4 Injection Laryngoplasty In some cases, voice therapy is highly successful in treating voice disorders; however, some individuals wish for further improvement once therapy has been maximized as glottal insufficiency may persist. Glottal insufficiency is a condition where individuals are unable to achieve complete glottic closure resulting in a weak and breathy voice due to air escaping during phonation. According to Zaretsky and Rice (1996), incomplete glottic closure can lead to aspiration, inability to produce an effective cough, and breathy hypophonia. For individuals with incomplete glottic closure as a result of airway reconstruction, injection laryngoplasty is offered as a means to improve medialization. Injection laryngoplasty is a procedure involving injection of viscous material into the vocal folds with the purpose of “bulking up” the folds to allow for medialization (Figure 1). This surgical procedure has gained popularity in recent years due to its low procedural cost, technical feasibility, and clinical efficacy (Phua et al., 2013). Indications for injection laryngoplasty include any of the following: vocal fold paresis or paralysis, vocal fold atrophy, vocal fold bowing, and vocal fold scarring. For an injection to be successful, the ideal injection material should be biocompatible and not cause local tissue reaction or fibrosis, be easy to prepare and use, and durable and resistant to reabsorption or migration (Phua et al., 2013). It should also 4 have low cost and should maintain the viscoelasticity of the vocal fold post-injection (Phua et al., 2013). There are currently three substances that are most commonly used for injection laryngoplasty (Restylane, Radiesse Voice Gel, and lipoinjections) (Mallur & Rosen, 2010); however, neither of the three meet all the aforementioned criteria. Restylane (Hyaluronic Acid) is made up of a synthetic material and is used for temporary augmentation. Individuals with Restylane injections have effects lasting 3-6 months before the body reabsorbs the material. Radiesse Voie Gel (Calcium Hydroxylapatite) is a firmer and longer lasting material than Restylane. Lastly, fat injections, also known as Lipoinjections, provide a more permanent correction of mild vocal fold weakness or paresis, which often results in incomplete vocal fold closure during voice production. In cases where lipoinjections are used, the material is injected to overmedialize the vocal fold past the midline as absorption is expected (Zaretsky & Rice, 1997). The aforementioned materials can be injected onto the vocal folds (unilaterally or bilaterally) or in the supraglottic region depending on the level of function determined through stroboscopic assessment. Currently, there is no research that provides information on which injection comes the closest to restoring vocal function and provides the best post-surgical laryngeal function. Injection laryngoplasty is a surgical treatment alternative to laryngeal framework surgery and though each injection material has its advantages and drawbacks, there is no formal algorithm that exists in comparing the vocal outcomes following each (Mallur & Rosen, 2010). 5 Subglottic Stenosis Abduction (pre injection) Adduction (pre injection) Adduction (post injection) Figure 1. Injection Laryngoplasty (Zacharias, S.) 1.5 Glottal Efficiency Phonatory control and consistency depends upon the dynamic management of the respiratory, laryngeal and resonator subsystems (Carroll et al., 1996). It is the respiratory system that provides the driving force behind phonation. Any alteration to the respiratory framework (i.e. the larynx, vocal cords, etc.) would undoubtedly result in changes in phonatory function. But how does one measure this change? Glottal efficiency (GE) has been identified as the quantitative measure of the ability of the larynx to convert the aerodynamic power generated by the pulmonary system into acoustic power transmitted through the vocal tract and measured at the lips (Titze, 1995). Kirsh and colleagues (2017) described GE as the ratio between acoustic power and aerodynamic power, where acoustic power is the intensity of sound that radiates from the mouth and aerodynamic power is the product of subglottic air pressure and flow rate. In other words, GE is the amount of work put into producing voice. Researchers (Zur et al., 2007) have analyzed GE in singers and their findings suggest that increasing subglottal pressure has a positive correlation with acoustic intensity. This correlation, however, is reliant on glottal adduction remaining unaltered. Given that airway reconstruction often results in disruption of the convergent-divergent motion of the vocal folds, this study aims to assess how injection laryngoplasty, with its goal to allow for improved vocal fold medialization, impacts GE. 6 1.6 Current study This study is motivated by the question of whether vocal fold outcomes of children with airway reconstruction differ post-injection laryngoplasty and how. In this study, laryngeal function outcomes (as measured by glottal efficiency) and perceptual characteristics (as measured by the pVHI) in children pre- and post- airway reconstruction following injection laryngoplasty were compared. It was expected that improvement in laryngeal function will be evident post-injection. The following questions were investigated in order to determine whether these changes are positive or negative and the extent of which contributing factors were influencing these changes: (1) it was hypothesized that vocal function would improve following injection laryngoplasty (per changes in GE), (2) it was also hypothesized that the parents’ perceptual characteristics of their child’s voice (functional, physical, and emotional scores) would improve post-injection laryngoplasty, (3) how, if at all, are GE and perceptual characteristics impacted by sex, type of injection material used, injection site, and type of airway reconstruction. 7 2. RESEARCH DESIGN AND METHODS 2.1 Participants This study was a retrospective case series and medical record review of 16 pediatric patients (7 females, 9 males) at the Pediatric Center for Voice Disorders at Cincinnati Children’s Hospital. Participants were identified for this study based on the following criteria from the medical record database: (1) history of airway surgery, (2) history of injection laryngoplasty, (3) pre- and post- injection acoustic and aerodynamic measurements, and (4) pre- and post-injection parent surveys (i.e. pVHI and Initial Intake History Form). Case history was acquired via the Initial Intake History Form (Appendix A). 2.2 Data Collection 2.2.1 Pediatric Voice Handicap Index The (pVHI) was given to parents to rate their child’s voice in the following categories: functional, physical and emotional well-being (Appendix B). Given the nature of the questions and the description of the negative effects of voices on their lives (e.g. my child’s voice is worse in the evening, my child tends to avoid communicating because of his/her voice, etc.), lower scores on the pVHI were indicative of good and/or improved vocal function. Overall scores could be as low as 0 and as high as 92. 2.2.2 Acoustic Data Upon completion of the Initial Intake History Form and pVHI, patients were taken to a soundproof booth where acoustic data were recorded using the Kay Elemetrics Computerized Speech Lab (CSL) (Kay Elemetrics Corp., Pinebrook, NJ) with the CSL Real-time Pitch. Subjects 8 were asked to perform various vocal tasks (as outlined in Figure 2 below) while being recorded with a microphone set 5 inches away from the mouth and placed in an off-axis position. Acoustic data collection Maximum Phonation Time (MPT): Take a deep breath and say “ah” for as long as possible x3 Glide up: Start with a low pitch “oo” and glide up to a high pitch “oo” x3 Glide down: Start with a high pitch “oo” and glide down to a low pitch “oo” x3 Repeat: “1, 2, 3 ah” and hold the “ah” for as long as possible x3 Repeat each sentence once: - Peter will keep at the peak. - My mama makes lemon muffins. - We were away a year ago. Loudness (using soundmeter): - “1, 2, 3 ah” using normal volume x3 - “ah” as loud as possible x3 Figure 2. Acoustic data collection. 2.2.3 Aerodynamic Data Aerodynamic data were collected using the KayPENTAX Phonatory Aerodynamic System (PAS) Model 6600 (KayPENTAX Corp., Lincoln Park, NJ) designed to measure airflow and pressure related to speech and voice production. During airflow assessment, subjects were fitted with PAS airflow masks and were asked to place them firmly on their faces while producing a prolonged vowel /a/. For the pressure measurements, subjects were trained to allow their lips to close firmly on the plastic tube within the mask while repeating the syllable /pa/ (Figure 2). 9 Aerodynamic data collection Airflow - Comfortable sustained phonation: “ah” for as long as possible x3 Pressure - Place straw in between lips - Say “pa pa pa pa pa” in one breath x3 Figure 3. Aerodynamic data collection. 2.2.4 Stroboscopy Upon completion of acoustic and aerodynamic data collection, subjects underwent a videolaryngostroboscopy evaluation using either a flexible distal chip transnasal endoscopy or a rigid endoscopy. During evaluation, subjects were asked to perform varying vocal tasks (i.e. say “ee”, vary pitch while saying “ee”, and repeat sentences used during the acoustic data collection) as researcher recorded findings on Stroboscopy evaluation form (Appendix C) and the Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) (Appendix D). Patients for whom injection laryngoplasty was suggested were seen again post-injection at the clinic. 2.2.5 Glottal Efficiency Acoustic and aerodynamic data from each participant were pulled in order to calculate both pre- and post- injection GE values. As previously mentioned, Kirsh et al. (2017) defined GE as the ratio between acoustic and aerodynamic power. For purposes of this study, their equation for this definition (GE ≈ Sound Pressure Level (SPL) / Psg x Q) was utilized. 10 2.3 Data Analysis Data from the Pediatric Voice Clinic at Cincinnati Children’s Hospital Medical Center were obtained via Redcap. Participants were chosen based on the criteria outlined for this study. Given that pVHI data for all 16 participants were not available, descriptive analyses were conducted to answer the first research question: it was hypothesized that the parents’ perceptual characteristics of their child’s voice (functional, physical, and emotional scores) would improve post-injection laryngoplasty. Aerodynamic and acoustic measurements were collected for calculation of GE with the goal to answer the first research question: it was hypothesized that vocal function would improve following injection laryngoplasty (per changes in GE). Once GE had been calculated both prior to and post injection, a value for percent change was derived. Given the different ordinal variables and abnormal distribution of data in this study, a Wilcoxon Rank Sum test was conducted for each parameter (i.e. sex, injection type, and injection material) by GE percent change to determine a rank correlation. This test allowed for investigation into the third research question: how, if at all, are GE impacted by sex, type of injection material used and site of injection. 11 3. RESULTS 3.1 Perceptual Outcomes Of the 16 participants in this study, complete pVHI data was only available for 10. Total pVHI scores could be as low as 0 and as high as 92, with lower scores correlating with an improvement in perceived vocal outcomes. Given the small sample size of this study, statistical analyses could not be conducted on this given data. On average, post-injection laryngoplasty, parents reported lower scores on the pVHI indicating an overall improvement in vocal outcomes (Table 1). Table 1. pVHI outcomes Min Max Mean SD Pre-injection 14 96 50.3 24.92 Post-injection 4 72 38.1 20.97 3.2 Glottal Efficiency GE percent change was calculated to provide a quantifiable value to improvement postinjection laryngoplasty. Majority (9) of the participants demonstrated improvement in GE, as demonstrated by calculating percent change (Table 2, Figure 4). Additionally, a larger amount of female participants (N=5) had a positive percent change vs male participants (N=3). Paired sample t-test indicated a non-significant increase (t(15)=.898, p=.383) in GE pre (M=9.51, SD=7.41) and post-injection laryngoplasty (M=11.98, SD=15.70). 12 Table 2. Participant demographics, age at airway reconstruction and injection and GE percent change Participant Sex Age at Airway Reconstruction Age at Injection % change 1 F 18 18 11.85 2 F 2 7 3.29 3 F 17 18 -11.66 4 M 3 12 -37.43 5 F 1 17 1.79 6 M 15 17 -72.17 7 F 8 11 300.41 8 M 18 20 31.71 9 M 1 13 -55.81 10 M 14 14 35.01 11 M 9 9 -13.67 12 M 21 20 263.53 13 F 2 9 102.74 14 F 5 13 116.14 15 M 1 10 -65.98 16 F 8 8 -5.22 13 Figure 4. GE pre- and post-injection laryngoplasty. The Wilcoxon Sum Rank test was administered to determine whether there was a significant interaction between GE percent change and sex, injection material and site of injection. Calculated median and interquartile ranges are outlined in Table 3. Table 3. Wilcoxon Sum Rank test median and interquartile range (IQR, 25th-75th percentile) of three parameters by GE Parameters Median IQR Male -36.2 -60.9, 9.0 Female 7.57 -1.72, 109.44 Radiesse VoiceGel -5.22 -55.81, 31.71 Restylane 3.28 -11.66, 102.74 Bilateral vocal fold -1.72 -35.01, 3.28 Unilateral vocal fold 0.10 -51.70, 183.13 Supraglottic -13.67 -13.67, -13.67 Sex Injection material Site of injection 14 Correlation values (Table 4) depict that although sex was the closest in interaction (p=.06), neither of the parameters including injection material (p=.43) or site of injection (p=.85) were found to be positively correlated with GE percent change. Table 4. Difference in glottal efficiency by sex, injection material and site of injection (p values) Parameters P value Sex .06 Injection material .43 Site of injection .85 Figures 5, 6 and 7 present the distribution of GE percent change by sex, injection material and site of injection, respectively. Figure 5. GE by Sex 15 Figure 6. GE by Injection Material Figure 7. GE by Site of Injection 16 4. DISCUSSION Although pediatric voice disorders are becoming more common, there is still a lack of information available regarding their evaluation and treatment (Theis, 2010). Children who undergo airway reconstruction are often left with dysphonic voices and as a result are negatively impacted in several aspects of their well-being. Research has been conducted in the previous years to study voice outcomes post-airway reconstruction; however, there is little in the literature that looks into vocal function following injection laryngoplasty. Upon initial assessment following laryngotracheal reconstruction, a physician will determine whether or not treatment for a voice disorder is warranted. Should this be the case, speech therapy is often the first recommendation. With speech therapy, the child has an opportunity to learn techniques to produce a more functional voice before more invasive procedures are discussed. Following completion of therapy, if a child or his/her parents feel as though further improvement is needed, injection laryngoplasty is introduced. Research has gone as far as to discuss when injection laryngoplasty is deemed appropriate as well as described the different materials used. Currently, there is no research that analyzes which injections are most effective in restoring vocal function. This study was created in hopes to fill the gaps in pediatric voice disorders research and to allow for more information to assist both medical and therapeutic intervention planning. Focus on GE as an outcome measure appears appropriate given that it portrays vocal function in numerical terms and creates the foundation for creation of an algorithm to be universally used in assessing voice. It is important to note that this equation used for calculating GE is relatively new to research in voice disorders. Although no statistically significant correlations were found between GE and injection material or site of injection, there appears to be potential for a correlation with gender (given a larger sample size). 17 It was also hypothesized that the parents’ perceptual characteristics of their child’s voice (functional, physical and emotional scores) would improve post-injection laryngoplasty. Given pre- and post- pVHI scores, this hypothesis was supported. Due to the small sample size available for this study, statistical analysis could not be completed however it appears as though parents are reporting increased vocal function with injection laryngoplasty. This study adds to the pediatric voice disorders and airway reconstruction literature in that it provides a foundation for further studies to follow in assessing vocal function outcomes following airway reconstruction and postinjection laryngoplasty. Research in this area can provide crucial information regarding maximizing functional vocal outcomes in the pediatric population. Given the nature of a pilot study, limitations are inevitable. One highly influential limitation of this study was the small sample size. Unfortunately, there are very few medical facilities for which pediatric voice disorders are evaluated and treated; Cincinnati Children’s Hospital Medical Center is one of these facilities. Although there was a large dataset from which the participants in this study were examined, only 17 participants met the aforementioned research criteria. Additionally, aerodynamic and acoustic measures can be challenging in the pediatric population (Theis, 2010) given noncompliance, lack of participation and inaccurate completion of tasks; therefore, limited data were available for analysis. An assigned numerical value for GE is relatively new to the world of voice. Unfortunately, no comparisons can be made with other studies to facilitate in the validity of this variable. 18 5. CONCLUSION In summary, overall, per parents’ report, participants (perceptually) did achieve improved vocal function following injection laryngoplasty. No correlations were found with GE and sex, injection material and site of injection, which may be due to the small sample size of this study. Additionally, although there was no significant difference in GE scores pre and post injection laryngoplasty, researchers suspect a larger sample size may result in significant findings. GE does provide a mathematical and quantifiable value to vocal function which could benefit assessment and treatment of voice disorders. As mentioned in Table 2, a positive increase in GE percent change was noted with female participants. A larger amount of male participants (N=5) demonstrated a decrease in GE than females (N=2). Further studies could assess whether these changes are correlated with age both at the time of surgery and injection laryngoplasty and how the impact of puberty may play a roll (i.e. differences in larynx size, vocal fold size/mass, etc.). This study was formed with the intention for other facilities to also conduct the same research so a formal algorithm can be formed to improve the assessment and treatment of children with airway reconstruction history. However, until this algorithm is formed and for treatment thereafter, the role of speech-language pathologists in treatment of pediatric dysphonia is vital. Speech language pathology, more specifically voice therapy, focuses on the restoration of proper vocal function to allow for adequate phonation. Results from this study could very well be attributed to several factors in this field, including: gender and anatomy (changes in the vocal tract and differences between males and females), sources of phonation and compensatory strategies (supraglottic phonation) and overall vocal fatigue. As demonstrated by the Wilcoxon Rank Sum Test, gender was the closest in correlation with GE. It is important to note that a larger amount of females demonstrated a positive percent change in GE post-injection laryngoplasty. Given puberty 19 and its effects on laryngeal function, it would be interesting for further studies to assess whether vocal tract differences and age of injection are correlated with this percent change. Additionally, the use of other laryngeal structures for phonation other than the vocal folds (i.e. supraglottic phonation) serves as a sufficient source of phonation for some individuals; however, others experience vocal fatigue and inability to produce a functional voice. Voice therapy teaches exercises that allow for more functional phonation and help reduce the use of compensatory strategies that are often acquired by children with SGS. It is necessary that the input of speech language pathologists be utilized in both the assessment and treatment of children with dysphonia. 20 APPENDICES 21 APPENDIX A Initial Intake History Form. Patient ID ______________________ Today’s Date ______/_____/______ Birth Date ______/_____/______ Why was your child referred to the Voice Clinic? Please circle all that apply. § My child is hoarse § My child has a quiet voice § My child’s physician referred us to this clinic § Other: ____________________________ Who referred your child? _______________________________________________________ MEDICAL HISTORY Was your child full-term? Yes1 No2 If no, how many weeks gestation _________ weeks Does your child have any of the following medical conditions? Down’s Syndrome Yes1 No2 Don’t know3 Eosinophilic Esphagitis (EE) Yes1 No2 Don’t know3 Head Trauma Yes1 No2 Don’t know3 Mental Retardation Yes1 No2 Don’t know3 Cerebral Palsy Yes1 No2 Don’t know3 Currently 1 2 In the past 3 1 2 Yes No Don’t know3 Gastrointestinal Reflux Yes No Don’t know Cancer Yes1 No2 Don’t know3 Yes1 No2 Don’t know3 Asthma Yes1 No2 Don’t know3 Yes1 No2 Don’t know3 Swallowing Disorder Yes1 No2 Don’t know3 Yes1 No2 Don’t know3 Heart Condition Yes1 No2 Don’t know3 Yes1 No2 Don’t know3 22 BPD Yes1 No2 Don’t know3 Yes1 No2 Don’t know3 Other Pulmonary Disease Yes1 No2 Don’t know3 Yes1 No2 Don’t know3 Other (Please describe)___________________________________________________________ My child is exposed to cigarette smoke. Daily Occasionally Never How much of the following beverages does your child drink per day? Water ______ cups (approximately 8 oz) Juice ______ cups (approximately 8 oz) Milk ______ cups (approximately 8 oz) Soda/Pop ______ cups (approximately 8 oz) AIRWAY HISTORY Was your child ever intubated (breathing tube through mouth)? Yes1 No2 Don’t know3 Did your child require multiple intubations? Yes1 No2 Don’t know3 Did your child require a tracheostomy tube? Yes1 No2 Don’t know3 If yes, for how long? _______weeks _____ months OR _______ years Does your child currently have a tracheostomy tube? Yes1 No2 If yes, does your child use a Passy Muir Valve? Yes1 No2 How many hours is the valve worn during the day? Yes1 No2 Does your child have any of the following symptoms? Stridor (noise when breathing) Always4 Sometimes5 Never6 Shortness of breath during exercise Always4 Sometimes5 Never6 Shortness of breath during speech Always4 Sometimes5 Never6 Snoring Always4 Sometimes5 Never6 VOICE HISTORY 23 Does your child have the following symptoms related to his or her voice? Frequent hoarseness Always4 Sometimes5 Never6 The volume of the voice is too soft Always4 Sometimes5 Never6 The volume of the voice is too loud Always4 Sometimes5 Never6 The voice sounds breathy or airy Always4 Sometimes5 Never6 The pitch of the voice is too high Always4 Sometimes5 Never6 The pitch of the voice is too low Always4 Sometimes5 Never6 Pain associated with voice use Always4 Sometimes5 Never6 Increased effort to use the voice Always4 Sometimes5 Never6 Fatigue during/after voice use Always4 Sometimes5 Never6 Does your child’s voice vary in quality throughout the day (e.g., worse in the morning or worse in the evening)? Yes1 No2 If yes, please describe ________________________________ Do you, your family, or others have a hard time understanding what your child says? Yes1 No2 If yes, please describe ________________________________ Describe your child’s typical amount of talking during the day (circle one). Excessive Normal Minimal Does your child overuse his/her voice during the day (screaming, shouting, crying, cheering)? Yes1 No2 If yes, please describe ________________________________ Is your child a singer? Yes1 No2 Yes1 If yes, does your child take singing lessons? 24 No2 SWALLOWING: Has your child ever had difficulty with feeding and/or swallowing? Yes1 No2 Don’t know3 If yes, has your child ever: Been NPO (not allowed to eat/drink by mouth)? Yes1 No2 Don’t know3 Required a G Tube for nutrition? Yes1 No2 Don’t know3 Had a restricted diet for the type of liquid or food consumed? Yes1 No2 Don’t know3 Coughed/choked during or after drinking/eating? Yes1 No2 Don’t know3 Had a voice change after drinking/eating? Yes1 No2 Don’t know3 Refused to drink or eat by mouth? Yes1 No2 Don’t know3 Had multiple lung infections due to swallowing difficulty? Yes1 No2 Don’t know3 DEVELOPMENTAL HISTORY: Were development milestones for: Motor skills (walking) Normal Delayed Communication (talking) Normal Delayed What is your child’s current grade in school? ______________ Is your child making appropriate progress in school (academically and socially)? Yes1 No2 Don’t know3 Has your child ever received speech therapy? Yes1 No2 Don’t know3 Is your child currently receiving speech therapy? Yes1 No2 Don’t know3 If your child has or is currently receiving speech therapy, what has been or is the focus of this therapy? (You may need to circle more than one area) In the past Currently Swallowing Swallowing 25 Articulation development Articulation development Language development Language development Voice quality Voice quality Other information that you feel is useful for the voice team: 26 APPENDIX B Pediatric Voice Parent Questionnaire and Pediatric Voice Handicap Index. The following is a list of questions regarding the impact of your child’s voice quality on his/her overall communication, development, education, social and family life. Any input or insight you have will be a great help to the CCHMC voice team: 1. Please describe your child’s voice: 2. Please describe how your child’s voice effects his/her overall ability to communicate within the home: 3. Please describe how your child’s voice effects his/her ability to communicate in social situations (play, recess, with friends): 4. Please describe how your child’s voice effects his/her ability to communicate in educational settings: 5. Are you satisfied with the support your child receives from his/her school regarding voice and communication? 6. If your child has a tracheotomy tube, are you satisfied with the level of support and care you receive from the schools? 7. Please describe the physical effort (e.g. gets tired, strains) your child experiences when using his/her voice: 8. Do you feel like your child’s voice has an impact on his/her general well-being and development? If yes, how? 9. Please describe any concerns your child has about his/her voice (e.g. sometimes embarrassed, sometimes avoids communication, never has a concern): 10. Other comments? Thank you 27 28 29 APPENDIX C Stroboscopy Evaluation Form. Type Rigid Flexible High speed Lesion UL VC Paralysis BL VC paralysis Scarring of VC Large Glottic Gap Vertical level of VC asymmetric Interartytenoid space Edema No edema Appearance of Vocal Folds Edema Erythema n/a Glottic closure Cannot rate Complete Incomplete Irregular Post gap Hourglass Spindle Ant gap n/a Laryngeal closure Cannot rate Complete Partial None Supraglottic compression Cannot rate None Lateral Anterior-post 30 Mixed n/a Supraglottic degree Cannot rate None Mild Moderate Severe n/a Vertical level Cannot rate Level Off level n/a Lt Vocal Fold Edge Cannot rate Straight Irregular Lesion Scarring n/a Rt Vocal Fold Edge Cannot rate Straight Irregular Lesion Scarring Lt Artytenoid mobility Cannot rate Normal Restricted Fixed n/a Rt Artytenoid mobility Cannot rate Normal Restricted Vibration source 31 Fixed n/a n/a Cannot rate True VF Ventricular folds Mixed Ary/Epi/Pet n/a Any simulated slow motion vibratory characteristics visible? Yes No Yes No Could the parameters be rated? Lt Mucosal Wave Cannot rate Normal Mild Moderate Severe Present/NR n/a Mild Moderate Severe Present/NR n/a Rt Mucosal Wave Cannot rate Normal Lt Amplitude Cannot rate Normal Mild Moderate Severe n/a Normal Mild Moderate Severe n/a Rt Amplitude Cannot rate Phase symmetry Cannot rate Symmetric Mild assym n/a 32 Mod assym Sev assym Phase closure Cannot rate Normal/equal closed Mild open Mod closed Mod open Sev closed Sev open Mild n/a Lt Non-Vibratory segment Cannot rate None 20-40% 40-60% 60-80% >80% n/a Rt Non-Vibratory segment Cannot rate None 20-40% 40-60% 33 60-80% >80% n/a APPENDIX D Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) Name:_____________________________ Date:___________ The following parameters of voice quality will be rated upon completion of the following tasks: 1. Sustained vowels, /a/ and /i/ for 3-5 seconds duration each. 2. Sentence production: a. The blue spot is on the key again. d. We eat eggs every Easter. b. How hard did he hit him? e. My mama makes lemon muffins. c. We were away a year ago. f. Peter will keep at the peak. 3. Spontaneous speech in response to: "Tell me about your voice problem." or "Tell me how your voice is functioning." Legend:C = Consistent I = Intermittent MI = Mildly Deviant MO =Moderately Deviant SE = Severely Deviant SCORE Overall Severity MI MO SE MI MO SE MI MO SE MI MO SE Roughness Breathiness Strain Pitch I /100 C I /100 C I /100 C I /100 C I /100 C I /100 C I /100 C I /100 (Indicate the nature of the abnormality): MI Loudness C MO SE (Indicate the nature of the abnormality): MI MO SE MI MO SE MI MO SE __________ __________ COMMENTS ABOUT RESONANCE: NORMAL OTHER (Provide description): ADDITIONAL FEATURES (for example, diplophonia, fry, falsetto, asthenia, aphonia, pitch instability, tremor, wet/gurgly, or other relevant terms): Clinician: 34 BIBLIOGRAPHY 35 BIBLIOGRAPHY Baker, S., Kelchner, L., Weinrich, B., Lee, L., Willging, P., Cotton, R., and Zur, K. (2006). Pediatric laryngotracheal stenosis and airway reconstruction: a review of voice outcomes, assessment, and treatment issues. Journal of Voice, 20(4): 631-641. Carroll, L.M., Sataloff, R.T., Heuer, R.J., Spiegel, J.R., Radionoff, S.L., and Cohn, J.R. (1996). Respiratory and glottal efficiency measures in normal classically trained singers. Journal of Voice, 10(2); 139-145. Kirsh, E., Zacharias, S.R.C., de Alarcon, A., Deliyski, D., Tabangin, M., and Khosla, S. (2017). Vertical phase difference and glottal efficiency in musical theater and opera singers. Journal of Voice, 31(1), 130.e19-130.e25. Lesperance, M.M., and Zalzal, G.H. (1998) Laryngotracheal stenosis in children. Eur Arch Otorhinolarngol; 255: 12-17. Mallur, P.S., and Rosen, C.A. (2010). Vocal fold injection: review of indications, techniques, and materials for augmentation. Clinical and Experiemtnal Otorhinolaryngology; 3(4): 177-182. Myer, C.M., O’Connor, D.M., and Cotton, R.T. (1994). Proposed grading system for subglottic stenosis based on endotracheal tube sizes. Ann Otol Rhinol Laryngol; 103(1): 319-323. Phua, C.Q., Mahalin-Gappa, Y., Homer, J., and Karagama, Y. (2013). Injection laryngoplasty. The Otorhinolaryngologist; 6(1): 111-118. Schwartz, S.R., Cohen, S.M., Dailey, S.H., Rosenfeld, R.M., Deutsch, E.S., Gillespie, B., Granieri, E., Hapner, E.R., Kimball, E., Krouse, H.J., McMurray, S., Medina, S., O’Brien, K., Ouellette, D.R., Messinger-Rapport, B.J., Stachler, R.J., Strode, S., Thompson, D.M., Stemple J.C., Willging, J.P., Cowley, T., McCoy, S., Bernad, P.G., and Patel, M.M. (2009). Clinical practice guidelines: hoarseness (dysphonia). Otolaryngology-Head and Neck Surgery, 141, S1-S31. Sell D., McCurtain F. (1988). Speech and language development in children with acquired subglottic stenosis. J Laryngol Otol Suppl; 17: 35–8. Sipp, J.A., Kerschner, J.E., Braune, N., and Hartnick, C.J. (2007). Vocal fold medialization in children: injection laryngoplasty, thyroplasty, or nerve reinnervation? Arch Otolaryngol Head Neck Surg, 133(8), 767-771. Sulica, L., Rosen, C.A., Postma, G.N., Simpson, B., Amin, M., Courey, M. and Merati, A. (2009). Current practice in injection augmentation of the vocal folds: indications, treatment principles, techniques, and complications. The Laryngoscope; 120: 319-325. 36 Theis, S.M. (2010). Pediatric voice disorders: evaluation and treatment. The ASHA Leader, 15: 12-15. Titze I.R., Riede T. (2010). A Cervid Vocal Fold Model Suggests Greater Glottal Efficiency in Calling at High Frequencies. PLoS Comput Biol 6(8): e1000897. doi:10.1371/journal.pcbi.1000897 Verdolini, K. (1998). Resonant voice therapy. National Center for Voice and Speech’s Guide to Vocolology. Iowa City, Iowa: National Center for Voice and Speech. Whigham AS, Howell R, Choi S, Peña M, Zalzal G, Preciado D. (2012). Outcomes of balloon dilation in pediatric subglottic stenosis. Ann Otol Rhinol Laryngol;121(7):442-448. White, D.R., and Rutter, M.J. (2009). Cricotracheal resection and reanastomosis. Operative Techniques in Otolaryngology; 20: 236-240. Wright, C.D. (2008). Surgical management of subglottic stenosis. Operative Techniques in Thoracic and Cardiovascular Surgery. 53-65. Zaretsky, L.S. and Rice D.H. (1996). Autologous fat injection for unilateral vocal fold paralysis. Ann Otol Rhinol Larngol; 105(6): 602-606. Zur, K.B., Cotton, S., Kelchner, L., Baker, S., Weinrich, B., Lee, L. (2007). Pediatric voice handicap index (pVHI): a new tool for evaluating pediatric dysphonia. International Journal of Pediatric Otorhinolaryngology; 71: 77-82. 37